로딩 중…
지수 로딩 중…
Denali Therapeutics Inc.
DNLI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$23.31-0.77%
2026-06-18
Price Chart
Denali Therapeutics Inc.+65.44%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.70B |
| Revenue | $0.00 |
| Net Income | $-508M |
| Total Assets | $1.27B |
| Net Assets | $926M |
| Value | |
| P/B | 3.99x |
| FCF Yield | -11.33% |
| Profitability | |
| ROE | -54.86% |
| ROA | -40.13% |
| Financial Health | |
| Debt Ratio | 36.71% |
| Total Debt | $40M |
| FCF | $-419M |
| Cash | $388M |
| Current Ratio | 9.28x |
| Performance | |
| 1Y Return | 65.44% |
| 1M Return | 28.71% |
| From 52W High | -5.42% |
| 1Y MDD | -23.42% |
| Trading | |
| Volume | 2,178,487 shares |
| Trading Value | $52M |
| Per Share | |
| EPS | $-2.92 |
| BPS | $5.78 |